Didactic Webinar Series

Fellowship WebinarThe ACTRIMS Didactic Webinar Series is offered nationally to neuroimmunology and MS fellows beginning in August 26, 2022.  An expert lecturer will present on niche topics to increase the educational yield for trainees. This series provides a forum for trainees to engage with advanced faculty on a scheduled basis.

Program

The Didactic Webinar Series will be held twice per month on Fridays from 4:00 – 5:00 PM ET. 

Goals:
  1. To use a virtual platform to provide national didactics on high-yield niche topics in neuroimmunology 
  2. To increase comfort levels among neuro-immunology trainees on high-yield niche topics in neuroimmunology
  3. To provide fellows with the opportunity for direct interactions with topic experts
  4. To facilitate discussion and networking among MS/Neuroimmunology trainees
Learning Objectives:
  1. Describe the tools underlying MS/Neuroimmunology evidence-based-practice, including trial design, lab-based testing and imaging
  2. Compare the pathogenic mechanisms underlying MS and other neuroimmunologic diseases
  3. Distinguish rare neuroimmune diseases and their mimics 
  4. Describe the issues affecting special populations (pediatric and advanced MS) and explain management strategies for these groups.
  5. Integrate cross-disciplinary tools to manage symptomatic concerns for MS and other neuroimmune diseases

CME Accreditation:
This webinar series has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Interstate Postgraduate Medical Association (IPMA) and ACTRIMS. Interstate Postgraduate Medical Association designations this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. A survey will be sent to all participants after each webinar to claim credit for that specific webinar. If you are unable to watch the live webinars, you may watch them on-demand and still receive a CME certificate. View the ACTRIMS Didactic Lecture Faculty Disclosures here

Registration
If you are a neuroimmunology and/or MS fellow, register here. Contact Emily Viles-Monari with questions. 

Register here
Date Topic Speaker
08/26/2022 Progressive Multifocal Leukoencephalopathy Joseph Berger, Penn Medicine
09/09/2022 Basic Science of Remyelination Wendy MacklinUniversity of Colorado
09/23/2022 Pathogenesis of Neurological Disability in MS Bruce Trapp, Cleveland Clinic
10/07/2022 MOGAD Erin Longbrake, Yale University
10/21/2022 Approach to Autoimmune Myelitis and its Mimics Eoin FlanaganMayo Clinic
ECTRIMS - October 26-28, 2022
11/4/2022 Neurosarcoidosis Jeff GelfandUniversity of California, San Francisco
11/18/2022 Lab Techniques and Tools Understanding Antibody-Mediated Diseases Andrew McKeon, Mayo Clinic
12/02/2022 Pediatric Multiple Sclerosis Brenda BanwellChildren’s Hospital of Philadelphia
12/16/2022 Urologic Case Studies Nina DavisOregon Health & Science University
New Year’s Day – January 1, 2023
01/06/2023 Advanced MRI Imaging Daniel Ontaneda, Cleveland Clinic
01/20/2023 Stem Cell Therapy and MS Jeffrey Cohen, Cleveland Clinic
02/03/2023 Antibody-Mediated Pathogenesis in MS Jeffrey BennettUniversity of Colorado
02/17/2023 To Be Announced To Be Announced
ACTRIMS Forum 2023 – February 23-25, 2023
03/03/2023 Progressive Multiple Sclerosis Robert Fox, Cleveland Clinic
03/17/2023 "Critical" Demyelinating Lesions Associated with Motor Mark Keegan, Mayo Clinic
03/31/2023 Pregnancy and MS Riley Bove, University of California, San Francisco
04/07/2023 To Be Announced To Be Announced
04/14/2023 To Be Announced To Be Announced
AAN Annual Meeting – April 22-27, 2023
05/05/2023 Adult-onset Leukodystrophies and Genetic Leukoencephalopathies Jennifer Orthmann Murphy, University of Pennsylvania
05/19/2023 Neurorestoration and Neurotechnology in Neuroinflammatory Disorders Mijail Serruya, Thomas Jefferson University
06/16/2023 Anti-NMAR Encephalitis Josep Dalmau, Penn Medicine